JAGU vs NNE vs UROY Stock Comparison

Jaguar Uranium, Nano Nuclear Energy and Uranium Royalty Prices as of Oct 29, 2026 Peers: Industry group

Head to Head

3 decided of 12

Uranium Royalty leads on 2 of the 12 questions below (Uranium Royalty 2, Nano Nuclear Energy 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionJAGUNNEUROYLeader
Larger companyMarket capitalisation $18.82M $572.15M $510.99M NNE
Cheaper on earningsLower P/E, profitable companies only -21.7x — 33.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 34.7x –
Faster revenue growthRevenue growth, trailing twelve months — — — –
More profitableNet margin, trailing twelve months — — — –
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months — -74.5% -27.9% UROY
Better 5-year returnAnnualised price return, 5 years — — -6.4%/yr –
Less volatileAnnualised volatility, 1 year 114.6% 88.9% 67.8% UROY
Higher overall scoreMean of the five percentile scores vs peers — — — –

Percentile Scorecard

JAGUNNEUROY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisJAGUNNEUROY
Valuation 59 #10 of 23 – 86 #4 of 23
Growth – – –
Profitability – – –
Financial Health 95 #2 of 22 – 10 #20 of 22
Shareholder Returns – – –
Overall – – –
  • JAGU ranked among 25 companies in Coal and Uranium
  • NNE ranked among 25 companies in Coal and Uranium
  • UROY ranked among 25 companies in Coal and Uranium

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodJAGUNNEUROYSPY
1 month -28.8%-22.7%-15.0% +0.7%
3 months -37.7%-26.8%+1.5% +3.7%
6 months -62.5%-47.8%-11.0% +7.1%
Year to date —-49.1%-2.0% +12.8%
1 year —-74.5%-27.9% +11.9%
3 years ——+29.0% +85.2%
3 years, per year ——+8.9% +22.8%
5 years ——-28.0% +67.6%
5 years, per year ——-6.4% +10.9%

Risk

MeasureJAGUNNEUROYSPY
Volatility, 1Y 114.6%88.9%67.8% 12.7%
Downside volatility, 1Y 105.1%87.4%68.0% 12.6%
Beta vs S&P 500, 1Y 2.654.112.34 1.00
Return / volatility, 1Y —-0.84-0.41 0.94
Max drawdown, 5Y -76.5%-79.1%-74.2% -25.4%
From 52-week high -76.5%-74.5%-36.4% -1.2%
52-week high $4.00$47.83$5.46 $779.14
52-week low $0.94$11.86$2.61 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleJAGUNNEUROY
P/E now vs peer median -21.7xmedian 27.1x —median 27.1x 33.5xmedian 27.1x
P/S now vs peer median 103.1xmedian 7.3x 131.7xmedian 7.3x 10.5xmedian 7.3x
EV/EBITDA now vs peer median —median 29.1x —median 29.1x —median 29.1x
P/FCF now vs peer median —median 10.3x —median 10.3x 10.3xmedian 10.3x
P/B now vs peer median 0.7xmedian 1.2x —median 1.2x 0.5xmedian 1.2x
PEG now vs peer median —median 50.94 —median 50.94 —median 50.94

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsJAGUNNEUROY
Cash & equivalents $413.34K $298.47M $103.65M
Total debt – – $592.76M
Shares (diluted) 20.19M 52.35M 157.28M
Enterprise value $18.82M -$717.59M $80.77M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricJAGUNNEUROY
P/E -21.7x – 33.5x
P/FCF – – 10.3x
P/Operating cash flow – – –
P/S 103.1x 131.7x 10.5x
P/B 0.7x – 0.5x
P/Tangible book 0.7x – 0.5x
EV/EBITDA – – –
EV/EBIT – – –
EV/Revenue – – –
EV/FCF – – –
EV/Operating cash flow – – –
PEG (3Y EPS CAGR) – – –

Growth

14 metrics
MetricJAGUNNEUROY
Revenue growth (1Y) – – –
Revenue CAGR (3Y) – – –
Gross profit growth (1Y) – – –
Gross profit CAGR (3Y) – – –
Operating income growth (1Y) – – –
Operating income CAGR (3Y) – – –
Net income growth (1Y) – – –
Net income CAGR (3Y) – – –
EPS growth (1Y) – – –
EPS CAGR (3Y) – – –
Operating cash flow growth (1Y) – – –
Operating cash flow CAGR (3Y) – – –
Free cash flow growth (1Y) – – –
Free cash flow CAGR (3Y) – – –

Profitability

14 metrics
MetricJAGUNNEUROY
Gross margin – – –
EBITDA margin – – –
Operating margin – – –
Pretax margin – – –
Net margin – – –
FCF margin – – –
Operating cash flow margin – – –
Return on equity – – –
Return on assets – – –
Return on invested capital – – –
Return on capital employed – – –
Asset turnover – – –
Cash conversion (OCF / net income) – – –
Stock comp / revenue – – –

Financial Health

11 metrics
MetricJAGUNNEUROY
Debt / assets – – 31.0%
Debt / equity – – 0.5x
Net debt / EBITDA – – –
Debt / FCF – – –
Liabilities / assets 6.9% – 42.9%
Equity / assets 93.1% – 57.1%
Interest coverage – – –
Current ratio 37.6x – 0.9x
Quick ratio 36.9x – 0.9x
Cash ratio 36.9x – 0.8x
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricJAGUNNEUROY
Dividend yield – – –
Net buyback yield – – –
Shareholder yield – – –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusJAGUNNEUROY
Forward P/E – – 34.7xFY2026
EPS, next fiscal year – $-0.76FY2026 $0.10FY2026
EPS growth, next FY – – -65.5%FY2026
EPS growth, the year after – – -120.0%
Revenue, next fiscal year – $1.84MFY2026 $89.43MFY2026
Revenue growth, next FY – – -52.2%FY2026
Revenue growth, the year after – +313.6% -50.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersJAGUNNEUROY
Held by institutions – 42.6% 9.4%
Institutions holding – 237 112
Change in shares held, QoQ – -0.8% -14.3%
Institutions buying – 128 53
Institutions selling – 55 37
Buyers to sellers – 2.33 1.43

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

JAGUNNEUROY
JAGU 1.00 0.27 0.22
NNE 0.27 1.00 0.57
UROY 0.22 0.57 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, JAGU, NNE and UROY?

Nano Nuclear Energy (NNE) is the largest by market capitalisation: Jaguar Uranium (JAGU) $18.82M, Nano Nuclear Energy (NNE) $572.15M, Uranium Royalty (UROY) $510.99M.

Which stock has performed better?

Over the past year Uranium Royalty (UROY) returned the most: Nano Nuclear Energy (NNE) -74.5%, Uranium Royalty (UROY) -27.9%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Uranium Royalty (UROY) has been the steadiest (Jaguar Uranium (JAGU) 114.6%, Nano Nuclear Energy (NNE) 88.9%, Uranium Royalty (UROY) 67.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, JAGU, NNE and UROY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Uranium Royalty (UROY) leads on 2. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.